Neha Mathur

Neha Mathur

MSc Biotechnology

Neha is a digital marketing professional based in Gurugram, India. She has a Master’s degree from the University of Rajasthan with a specialization in Biotechnology in 2008. She has experience in pre-clinical research as part of her research project in The Department of Toxicology at the prestigious Central Drug Research Institute (CDRI), Lucknow, India. She also holds a certification in C++ programming.

See more

She started her career as a content writer and over the years, earned extensive experience in writing, working with companies in diverse sectors, including Information Technology, Intellectual Property, a naval architectural company, and a payment wallet company.

She has conceptualized and managed all content touchpoints, including blogs, transactional and promotional communication, ensuring all the content is brand consistent and SEO optimized across all marketing channels - mobile app, website, social media, emails, and offline channels.

She has extensive experience in Email marketing with knowledge of marketing automation tools, such as Oracle Responsys and Netcore Smartech. As part of her role in Marketing Communications teams, she has handled in-house content management systems, cross-channel marketing programs, transactional and promotional messaging, and large-scale marketing programs to drive business growth.

During her tenure at Oxigen Services Pvt. Ltd., a payment wallet company, she developed a keen interest in Volunteering. She participated in the E&Y Global Partnership Summit held in New Delhi in 2017 and earned laurels as part of the Behind the Scenes Team.

Neha is passionate about secondary research, marketing analytics, and medical writing. In her free time, Neha loves to read fiction, experiment with new recipes, and read stories to her daughter Ashna or play with her.

See less

Articles from Neha

Epidemic model shows that intermediate levels of asymptomatic SARS-CoV-2 infection lead to the highest levels of epidemic fatalities

Epidemic model shows that intermediate levels of asymptomatic SARS-CoV-2 infection lead to the highest levels of epidemic fatalities

Study uses digital technology to evaluate antibody response following COVID-19 boosters

Study uses digital technology to evaluate antibody response following COVID-19 boosters

Memory B and T cell responses to the SARS-CoV-2 spike protein before and after the third BNT162b2 booster

Memory B and T cell responses to the SARS-CoV-2 spike protein before and after the third BNT162b2 booster

The role of the biochemical features of the SARS-CoV-2 spike protein in human transmission

The role of the biochemical features of the SARS-CoV-2 spike protein in human transmission

The antibody evasion properties of the SARS-CoV-2 Omicron subvariant BA.2.75

The antibody evasion properties of the SARS-CoV-2 Omicron subvariant BA.2.75

Study explores differential antibody-mediated effector functions evoked by two mRNA-based COVID-19 vaccines

Study explores differential antibody-mediated effector functions evoked by two mRNA-based COVID-19 vaccines

Plasma myosin light chain 9 levels may be better predictor of COVID-19 severity than blood biomarkers

Plasma myosin light chain 9 levels may be better predictor of COVID-19 severity than blood biomarkers

Study highlights the urgent need to evaluate deficiencies in the energy balance model for the prevention and treatment of obesity

Study highlights the urgent need to evaluate deficiencies in the energy balance model for the prevention and treatment of obesity

How does Omicron BA.1 infection impact the risk of reinfection with BA.5?

How does Omicron BA.1 infection impact the risk of reinfection with BA.5?

The efficacy of honokiol in inhibiting SARS-CoV-2 replication in cell culture

The efficacy of honokiol in inhibiting SARS-CoV-2 replication in cell culture

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.